$LWLG Major Website Update on LWLG Roadmap! PHOTONICS

New Post Public Reply Private Reply Replies (0) Message Board
mc67
293
$LWLG Major Website Update on LWLG Roadmap!

PHOTONICS PRODUCT DEVELOPMENT ROADMAP

Lightwave Logic is developing a flexible technology platform that can support a variety of product configurations. The central element of the platform is a high-speed modulator device that can be integrated in multiple ways depending on the target application. Shown below are some of the wide range of potential modulator products based on the same nominally 50 Gbps (more accurately 50 Gbaud) device. 100 Gbps and 400 Gbps are highlighted as popular datacom applications. The total aggregate bitrate capacity shown below ranges from 50 Gbps to 800 Gbps depending on:

- The number of devices integrated into a single chip

- The way the device is used. PAM-4 modulation is an industry-standard approach that doubles the effective bitrate of the a device.

100 Gbps and 400 Gbps are popular datacom applications highlighted in the diagram below.

(see link at end of post to view diagrams)

DEVELOPMENT ROADMAP STEPS RELEVANT TO A 50 GBPS MODULATOR PRODUCT:

- 50 Gbps RWG Modulator, Optimizing chip and package parameters: At the May Annual Shareholder Meeting, the company showed operational 50Gbps Ridge Waveguide Modulators. The company also noted that it was continuing to optimize the parameters for devices into packaged prototypes. Each customer has their own set of parameters for integration with a fiber optic communications equipment. We expect that the on-going chip and device level optimization will continue to be an integral part of engagement with customers.

- 50 Gbps RWG Modulator (Packages for R&QA and customer evaluation): The company has initiated R&QA (reliability and quality assurance) on the modulator and is engaging with customers as part of the evaluation phase of product development. We expect that the on-going package and R&QA activities will continue as an integral part of engagement with customers.

- 50 Gbps RWG modulator design on PIC platform: While initial customer testing can be done with the devices and packages above, the company has stated that its long-term goals is a multichannel Polymer Photonic Integrated Circuit (P2IC™) platform. The company has initiated initial designs of a more advanced 50Gbps RWG modulator device using a PIC platform. As part of this design function, the roadmap calls out for the completion of the modeling and simulation architecture, and the company is pleased to note that progress is on target.

DEVELOPMENT ROADMAP STEPS RELEVANT TO 100 GBPS MODULATOR PRODUCT:

- All the 50 Gbps steps above, plus...

- Drive 50 Gbps (50 Gbaud) RWG modulator with PAM-4: PAM-4 is an industry-standard approach that doubles the effective bitrate of device. With PAM-4, the nominally "50 Gbps" device can address the large 100 Gbps market.

- Alternatively, a base rate of 100 Gbps modulator RWG modulator design: The company is excited that early results from the 50 Gbps program look promising for direct native 100 Gbps (a 100 Gbaud device that does not require the use of PAM-4 to reach 100 Gbps) as well on this technology platform.

DEVELOPMENT ROADMAP STEPS RELEVANT TO 400 GBPS MODULATOR PRODUCT:

- All steps for 50 Gbps modulator product plus the following additional step

- Multiple 50 Gbps RWG modulators (either 4 or 8) can be combined (integrated) in a single chip for an aggregated data rate of 400 Gbps

https://lightwavelogic.com/Photonics_Product_Roadmap

- proto

Lightwave Logic Inc (LWLG) Stock Research Links

LWLG Board Company Profile Buy Rating Time & Sales News Filings Financials
$MJ
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 222

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 288

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 202

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading

Top 5 Most Recently Viewed Articles

Alto Neuroscience, Inc. Faces Class Action Lawsuit Risk

Updated Category News Views 181

Class Action Lawsuit Against Alto Neuroscience, Inc. Alto Neuroscience, Inc. (NYSE: ANRO) is currently facing a class action lawsuit filed by a national shareholder rights litigation firm. This lawsuit revolves around allegations of securities fraud, claiming the company made misleading statements regarding the efficacy of its product ALTO-100 in treating major depressive...

Continue Reading
Hyatt and Playa Hotels Explore Strategic Partnership Options

Updated Category News Views 218

Hyatt Engages in Exclusive Discussions with Playa Hotels Hyatt Hotels (NYSE: H) is currently in exclusive negotiations regarding a potential takeover of Playa Hotels & Resorts (NASDAQ: PLYA) N.V. This engagement marks a significant move for both companies as they explore various strategic options for the $1.2 billion resort operator. The announcement has generated...

Continue Reading
LingoAce Celebrated as Top Innovator in Global Education Market

Updated Category News Views 111

LingoAce Celebrated as Top Innovator in Global Education Market Pioneering Tech-driven, Personalized Learning for over 580,000 Learners Worldwide LingoAce, a prominent global EdTech company, has received recognition as a 2025 Forbes China Influential Brand in Education. This honor was presented during the inaugural 2025 Forbes China Educational Industry Summit,...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 138

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
NV5 Global Backs Major Coastal Mapping Initiative in New Zealand

Updated Category News Views 197

NV5 Global Secures $4 Million Coastal Mapping Contract NV5 Global, Inc. (NASDAQ: NVEE), a significant player in the professional engineering field, has recently secured a noteworthy contract with Toit? Te Whenua Land Information New Zealand (LINZ) for a $4 million coastal mapping project. This contract is an important milestone in NV5's effort to expand its international...

Continue Reading